GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » 5-Year Yield-on-Cost %

Oncodesign Precision Medicine (XPAR:ALOPM) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine 5-Year Yield-on-Cost %?

Oncodesign Precision Medicine's yield on cost for the quarter that ended in Jun. 2022 was 0.00.


The historical rank and industry rank for Oncodesign Precision Medicine's 5-Year Yield-on-Cost % or its related term are showing as below:



XPAR:ALOPM's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.955
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Oncodesign Precision Medicine's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Oncodesign Precision Medicine's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncodesign Precision Medicine's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's 5-Year Yield-on-Cost % falls into.



Oncodesign Precision Medicine 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Oncodesign Precision Medicine is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Oncodesign Precision Medicine  (XPAR:ALOPM) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Oncodesign Precision Medicine 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines